Cargando…

Multiple ETS Factors Participate in the Transcriptional Control of TERT Mutant Promoter in Thyroid Cancers

SIMPLE SUMMARY: Mutations in the promoter region of the telomerase reverse transcriptase (TERT) gene are enriched in patients with advanced thyroid tumors. Their consequence is the reactivation of TERT expression through mechanisms that involve specific transcription factors and other signaling inpu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thornton, Caitlin E. M., Hao, Jingzhu, Tamarapu, Prasanna P., Landa, Iñigo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774187/ https://www.ncbi.nlm.nih.gov/pubmed/35053525 http://dx.doi.org/10.3390/cancers14020357

Ejemplares similares

Telomerase reactivation induces progression of mouse Braf(V600E)-driven thyroid cancers without telomere lengthening
por: Landa, Iñigo, et al.
Publicado: (2023)

Thyroid transcription factor FOXE1 interacts with ETS factor ELK1 to co-regulate TERT
por: Bullock, Martyn, et al.
Publicado: (2016)

Structural basis for reactivating the mutant TERT promoter by cooperative binding of p52 and ETS1
por: Xu, Xueyong, et al.
Publicado: (2018)

TERT Promoter Mutations Increase Sense and Antisense Transcription from the TERT Promoter
por: Hafezi, François, et al.
Publicado: (2021)

The ETS Inhibitor YK-4-279 Suppresses Thyroid Cancer Progression Independent of TERT Promoter Mutations
por: Xue, Junyu, et al.
Publicado: (2021)

Advances in Thyroid Carcinoma
por: Landa, Iñigo
Publicado: (2022)

TERT Immunohistochemistry Is a Poor Predictor of TERT Promoter Mutations and Gene Expression in Follicular Thyroid Carcinoma
por: Paulsson, Johan O., et al.
Publicado: (2018)

Targeted Long-Read Bisulfite Sequencing Identifies Differences in the TERT Promoter Methylation Profiles between TERT Wild-Type and TERT Mutant Cancer Cells
por: Lee, Seungjae, et al.
Publicado: (2022)

Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer
por: Panebianco, Federica, et al.
Publicado: (2019)

TERT accelerates BRAF mutant–induced thyroid cancer dedifferentiation and progression by regulating ribosome biogenesis
por: Yu, Pengcheng, et al.
Publicado: (2023)

Aggressive differentiated thyroid cancer with multiple metastases and NRAS and TERT promoter mutations: A case report
por: Pani, Fabiana, et al.
Publicado: (2017)

Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers
por: Stern, Josh Lewis, et al.
Publicado: (2015)

TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF(V600E)/TERT promoter double-mutated glioma
por: Gabler, Lisa, et al.
Publicado: (2019)

Genome-wide screens identify specific drivers of mutant hTERT promoters
por: Shanmugam, Raghuvaran, et al.
Publicado: (2022)

GABP couples oncogene signaling to telomere regulation in TERT promoter mutant cancer
por: McKinney, Andrew M., et al.
Publicado: (2022)

TERT Promoter Mutations and Tumor Persistence/Recurrence in Papillary Thyroid Cancer
por: Myung, Jae Kyung, et al.
Publicado: (2016)

Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations
por: Park, Hyunju, et al.
Publicado: (2021)

Radiomic study on preoperative multi‐modal magnetic resonance images identifies IDH‐mutant TERT promoter‐mutant gliomas
por: Wang, Haoyu, et al.
Publicado: (2022)

Low Prevalence of Somatic TERT Promoter Mutations in Classic Papillary Thyroid Carcinoma
por: Jeon, Min Ji, et al.
Publicado: (2016)

Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations
por: Hahn, Soo Yeon, et al.
Publicado: (2017)

The role of TERT promoter mutations in postoperative and preoperative diagnosis and prognosis in thyroid cancer
por: Jin, Anqi, et al.
Publicado: (2018)

TERT Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma
por: Rusinek, Dagmara, et al.
Publicado: (2020)

TERT promoter mutations and monoallelic activation of TERT in cancer
por: Huang, F W, et al.
Publicado: (2015)

hTERT promotes tumor angiogenesis by activating VEGF via interactions with the Sp1 transcription factor
por: Liu, Ning, et al.
Publicado: (2016)

The HHMI National Genomics Research Initiative at Western Kentucky University
por: King, Rodney A, et al.
Publicado: (2010)

TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas
por: Melo, Miguel, et al.
Publicado: (2014)

Advances in Detecting Low Prevalence Somatic TERT Promoter Mutations in Papillary Thyroid Carcinoma
por: da Costa, Vitor Rodrigues, et al.
Publicado: (2021)

Prospective Analysis of TERT Promoter Mutations in Papillary Thyroid Carcinoma at a Single Institution
por: Choi, Yun-Suk, et al.
Publicado: (2021)

Proposal of a New Prognostic Model for Differentiated Thyroid Cancer with TERT Promoter Mutations
por: Park, Jun, et al.
Publicado: (2021)

Allele‐specific proximal promoter hypomethylation of the telomerase reverse transcriptase gene (TERT) associates with TERT expression in multiple cancers
por: Rowland, Teisha J., et al.
Publicado: (2020)

LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma
por: Hou, Xiukun, et al.
Publicado: (2021)

A Qualitative Signature to Identify TERT Promoter Mutant High-Risk Tumors in Low-Grade Gliomas
por: Zheng, Weicheng, et al.
Publicado: (2022)

Mouse Models as a Tool for Understanding Progression in Braf(V600E)-Driven Thyroid Cancers
por: Landa, Iñigo, et al.
Publicado: (2019)

TERT promoter mutations and gene amplification: Promoting TERT expression in Merkel cell carcinoma
por: Xie, Hong, et al.
Publicado: (2014)

BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients
por: Sun, Jian, et al.
Publicado: (2016)

BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients
por: Jin, Langping, et al.
Publicado: (2016)

TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas
por: Bullock, Martyn, et al.
Publicado: (2016)

TERT Promoter Mutations Are an Independent Predictor of Distant Metastasis in Middle Eastern Papillary Thyroid Microcarcinoma
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2022)

Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients
por: Yang, Heera, et al.
Publicado: (2022)

Deep Learning Prediction of TERT Promoter Mutation Status in Thyroid Cancer Using Histologic Images
por: Kim, Jinhee, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_skqerjonl3ql76i1lnek8s74k9